ACHFF (Arch Biopartners) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Arch Biopartners FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Arch Biopartners's Free Cash Flow for the three months ended in Dec. 2024 was $-0.63 Mil. Arch Biopartners's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Arch Biopartners's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Arch Biopartners's current FCF Yield % is -1.27%.

The historical rank and industry rank for Arch Biopartners's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Arch Biopartners was -1255.26%. The lowest was -1255.26%. And the median was -1255.26%.

ACHFF's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -129.705
* Ranked among companies with meaningful FCF Margin % only.

Arch Biopartners FCF Margin % Historical Data

The historical data trend for Arch Biopartners's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners FCF Margin % Chart

Arch Biopartners Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

FCF Margin %

Get a 7-Day Free Trial

Arch Biopartners Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Arch Biopartners's FCF Margin %

For the Biotechnology subindustry, Arch Biopartners's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Arch Biopartners FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Arch Biopartners's FCF Margin for the fiscal year that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2024 )	/	Revenue (A: Sep. 2024 )
	=	-1.721	/	0
	=	%

Arch Biopartners's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-0.634	/	0
	=	%

Arch Biopartners FCF Margin % Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ARCH:Canada

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.